Therefore, increasing numbers of antibody markers, such as those against oxidized LDL for atherosclerosis [58], p53 antibodies for cancer [59], and glutamic acid decarboxylase antibodies for type-1 DM [60], have been developed for practical use. Here, TP53 is linked to cancer.